Cancer News and Research

Latest Cancer News and Research

University of Michigan to develop novel therapy for neuropathic pain

Researchers from the University of Michigan Department of Neurology have received a $1.8 million dollar grant to develop a novel therapy for neuropathic pain, a difficult to treat condition in which patients experience pain because of damage to nerve without obvious tissue injury.

10 Nov 2009

New technique to identify patients more likely to survive advanced melanoma

Although the chances of surviving advanced melanoma aren't very good with current therapies, some patients can live for years with cancer that has spread beyond the skin to other organs. Now it may be possible to identify which patients are more likely to survive by analyzing the activity of hundreds of genes involved in the immune response and gene proliferation, according to researchers at NYU Langone Medical Center.

10 Nov 2009

FDA approves Istodax for treatment of Cutaneous T-cell Lymphoma

The U.S. Food and Drug Administration has approved Istodax (romidepsin), an injectable medication, for treatment of patients with a rare form of cancer known as Cutaneous T-cell Lymphoma (CTCL).

10 Nov 2009

FDA accepts ChemGenex Pharmaceuticals' NDA for Omapro

ChemGenex Pharmaceuticals Limited announced today that the U.S. Food & Drug Administration (FDA) has accepted the company’s New Drug Application (NDA) for Omapro™ (omacetaxine mepesuccinate) for the treatment of patients with chronic myeloid leukemia (CML) who have failed treatment with imatinib and who have developed the Bcr-Abl T315I mutation.

10 Nov 2009

WHO report calls for improved health care for women, girls

A new WHO report, released Monday, said women tend to "receive poorer quality care throughout their lives, particularly as teenagers and elderly people" even though they live six to eight years longer than men, Reuters reports. The WHO said women worldwide are "'denied a chance to develop their full human potential' because many of their critical medical needs are ignored" (MacInnis, 11/9).

10 Nov 2009

Awareness campaign for Children’s Neuroblastoma Cancer Foundation wins GCG Marketing honors

GCG Marketing today announces its award of Best Corporate Advertisement/Campaign at the 2009 Medical Marketing & Media Awards honoring the agency’s development of an awareness campaign for the Children’s Neuroblastoma Cancer Foundation.

9 Nov 2009

St. Jude Children's Research Hospital patients to receive proton therapy at the UF Proton Therapy Institute

St. Jude Children's Research Hospital and the University of Florida Proton Therapy Institute have formed a collaboration to provide proton therapy for St. Jude patients. The announcement follows the approval of the first clinical study to evaluate the use of proton therapy for rare brain cancers in children younger than 3 years old.

9 Nov 2009

Black Diamond Video’s Integrated Digital Surgical Suites to be installed at the Yale-New Haven Hospital

Black Diamond Video, Inc. announces that Yale-New Haven Hospital has selected BDV to install their state-of-the-art Integrated Digital Surgical Suites (IDSS) into their neurosurgical suite and gastrointestinal suites in the new Smilow Cancer Center.

9 Nov 2009

Scientific article supports AEterna Zentaris' development of perifosine inhibitor

AEterna Zentaris Inc., a global biopharmaceutical company focused on endocrine therapy and oncology, today announced publication of a scientific article in the renowned Journal of Urology, supporting the development of the Company's PI3K/Akt pathway inhibitor oral compound, perifosine, for the treatment of cancer.

9 Nov 2009

Smoking has a direct negative impact on postoperative outcomes

With the American Cancer Society's Great American Smokeout Challenge just a week away, the American Society of Anesthesiologists (ASA) is giving smokers yet another reason to quit. The scientific evidence is clear -- smoking has a direct negative impact on postoperative outcomes. Quitting smoking is one of the best things people can do to improve their chances of recovering from surgery without complications.

9 Nov 2009

Chicago Prostate Cancer Center offers free prostate cancer guide

Prostate cancer is the second most common cancer in American men. One in six men will be diagnosed during his lifetime, according to the American Cancer Society.

9 Nov 2009

CytRx reports financial results for the three months and nine months ended September 30, 2009

CytRx Corporation, a biopharmaceutical company, today reported financial results for the three months and nine months ended September 30, 2009.

9 Nov 2009

Enzon Announces to sell its specialty pharmaceutical business to the sigma-tau Group for $300 million

Enzon Pharmaceuticals, Inc. (Nasdaq: ENZN) today announced that it has entered into a definitive agreement to sell its specialty pharmaceutical business to the sigma-tau Group for $300 million plus an additional amount of up to $27 million based on success milestones. Enzon will also receive royalties of 5 to 10 percent on incremental net sales above a 2009 baseline amount from Enzon’s four marketed specialty pharmaceutical products through 2014.

9 Nov 2009

Decision Resources forecasts sales of HER2-targeting agents to grow by 3.3% per year

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, in 2008, human epidermal growth factor receptor 2 (HER2) targeting therapies -- which include Roche/Chugai's Herceptin and GlaxoSmithKline/Nippon Kayaku's Tykerb/Tyverb -- were the highest-selling drug class in breast cancer treatment.

9 Nov 2009

Progenics Pharmaceuticals reports financial results for the third quarter of 2009

Progenics Pharmaceuticals, Inc. today announced its results of operations for the third quarter and nine months ended September 30, 2009.

9 Nov 2009

Public health experts urge Congress not to overlook the needs of Americans with "morbid obesity"

As the House of Representatives and the Senate debate companion bills to make health care more affordable and accessible, a coalition of obesity and public health experts today urged Congress not to overlook the needs of the more than 15 million Americans who suffer from severe obesity and are at the greatest risk for chronic disease and death.

9 Nov 2009

Clinical Data announces financial results for its second fiscal quarter ended September 30, 2009

Clinical Data, Inc. today announced the Company’s operational and financial results for its second fiscal quarter ended September 30, 2009.

9 Nov 2009

GTx reports financial results for the third quarter of 2009

GTx, Inc. today reported financial results for the third quarter of 2009. The net loss for the third quarter and nine months ended September 30, 2009 was $12.8 million and $35.4 million, respectively, compared with a net loss of $11.9 million and $37.9 million for the same periods in 2008. At September 30, 2009 GTx had cash, cash equivalents and short-term investments of $55.5 million.

9 Nov 2009

Chinese SFDA approves China Medical Technologies' Leukemia BCR/ABL fusion gene detection FISH Probe

China Medical Technologies, Inc., a leading China-based medical device company that develops, manufactures and markets advanced in-vitro diagnostic products, today announced that the Company has received approval for its Leukemia BCR/ABL fusion gene detection FISH Probe (the "Leukemia BCR/ABL FISH Probe") from the State Food and Drug Administration of China (the "SFDA").

9 Nov 2009

Simcere Pharmaceutical Group signs agreement to acquire manufacturing license from Tianjin Tianda Pharmaceutical

Simcere Pharmaceutical Group, a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded generic and proprietary pharmaceuticals in China, today announced an agreement to acquire the manufacturing license in China of Rosuvastatin from Tianjin Tianda Pharmaceutical Co., Ltd. ("Tianda").

9 Nov 2009

Cancer News and Research

Latest Cancer News and Research

University of Michigan to develop novel therapy for neuropathic pain

New technique to identify patients more likely to survive advanced melanoma

FDA approves Istodax for treatment of Cutaneous T-cell Lymphoma

FDA accepts ChemGenex Pharmaceuticals' NDA for Omapro

WHO report calls for improved health care for women, girls

Awareness campaign for Children’s Neuroblastoma Cancer Foundation wins GCG Marketing honors

St. Jude Children's Research Hospital patients to receive proton therapy at the UF Proton Therapy Institute

Black Diamond Video’s Integrated Digital Surgical Suites to be installed at the Yale-New Haven Hospital

Scientific article supports AEterna Zentaris' development of perifosine inhibitor

Smoking has a direct negative impact on postoperative outcomes

Chicago Prostate Cancer Center offers free prostate cancer guide

CytRx reports financial results for the three months and nine months ended September 30, 2009

Enzon Announces to sell its specialty pharmaceutical business to the sigma-tau Group for $300 million

Decision Resources forecasts sales of HER2-targeting agents to grow by 3.3% per year

Progenics Pharmaceuticals reports financial results for the third quarter of 2009

Public health experts urge Congress not to overlook the needs of Americans with "morbid obesity"

Clinical Data announces financial results for its second fiscal quarter ended September 30, 2009

GTx reports financial results for the third quarter of 2009

Chinese SFDA approves China Medical Technologies' Leukemia BCR/ABL fusion gene detection FISH Probe

Simcere Pharmaceutical Group signs agreement to acquire manufacturing license from Tianjin Tianda Pharmaceutical

Understanding the DNA Damage Response in Innate Immunity eBook

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Cancer News and Research

Latest Cancer News and Research

Understanding the DNA Damage Response in Innate Immunity eBook

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Newsletters you may be interested in